Sorry, you need to enable JavaScript to visit this website.

PREMPRO® AND PREMPHASE® (conjugated estrogens and medroxyprogesterone acetate) Contraindications

4 CONTRAINDICATIONS

PREMPRO or PREMPHASE therapy should not be used in women with any of the following conditions:

  • Undiagnosed abnormal genital bleeding
  • Known, suspected, or history of breast cancer
  • Known or suspected estrogen-dependent neoplasia
  • Active DVT, PE, or a history of these conditions
  • Active arterial thromboembolic disease (for example, stroke and MI), or a history of these conditions
  • Known anaphylactic reaction or angioedema to PREMPRO/PREMPHASE
  • Known liver dysfunction or disease
  • Known protein C, protein S, or antithrombin deficiency, or other known thrombophilic disorders
  • Known or suspected pregnancy

What's New

No Current Announcements.

Contact Pfizer Medical

Search

Please enter your search term(s) for PREMPRO® AND PREMPHASE®